Samsung Biologics to add new CMO orders at US Rockville factory, eyes further global expansion
Samsung Biologics has confirmed it will add new contract manufacturing organization (CMO) orders to its recently acquired factory in Rockville, Maryland, on top of the commercial pharmaceutical products already produced there. The company also formally laid out a roadmap to expand its global manufacturing footprint further within the next few years, with the US acquisition serving as the first step.
Samsung Biologics has confirmed it will add new contract manufacturing organization (CMO) orders to its recently acquired factory in Rockville, Maryland, on top of the commercial pharmaceutical products already produced there. The company also formally laid out a roadmap to expand its global manufacturing footprint further within the next few years, with the US acquisition serving as the first step.
Share article
Related Content